Fibroadenoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* In 1994, Dupont et al addressed in their retrospective cohort study that fibroadenoma is associated with a long term risk of invasive breast cancer, with the risk further increased in women with complex fibroadenomas, a family history of breast cancer and those with proliferative disease. Later in a study with Carter, they found that the presence of atypic within a fibroadenoma cannot foretell the presence of one in the adjacent breast parenchyma. They also found that atypia within a fibroadenoma does not present a relevant risk of development of breast cancer greater than that of a fibroadenoma with no atypia within.<ref name="pmid8202095">{{cite journal| author=Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS et al.| title=Long-term risk of breast cancer in women with fibroadenoma. | journal=N Engl J Med | year= 1994 | volume= 331 | issue= 1 | pages= 10-5 | pmid=8202095 | doi=10.1056/NEJM199407073310103 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8202095 }} </ref><ref name="pmid11443606">{{cite journal| author=Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA et al.| title=No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. | journal=Cancer | year= 2001 | volume= 92 | issue= 1 | pages= 30-6 | pmid=11443606 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11443606 }} </ref> | * In 1994, Dupont et al addressed in their retrospective cohort study that fibroadenoma is associated with a long term risk of invasive breast cancer, with the risk further increased in women with complex fibroadenomas, a family history of breast cancer and those with proliferative disease. Later in a study with Carter, they found that the presence of atypic within a fibroadenoma cannot foretell the presence of one in the adjacent breast parenchyma. They also found that atypia within a fibroadenoma does not present a relevant risk of development of breast cancer greater than that of a fibroadenoma with no atypia within.<ref name="pmid8202095">{{cite journal| author=Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS et al.| title=Long-term risk of breast cancer in women with fibroadenoma. | journal=N Engl J Med | year= 1994 | volume= 331 | issue= 1 | pages= 10-5 | pmid=8202095 | doi=10.1056/NEJM199407073310103 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8202095 }} </ref><ref name="pmid11443606">{{cite journal| author=Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA et al.| title=No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. | journal=Cancer | year= 2001 | volume= 92 | issue= 1 | pages= 30-6 | pmid=11443606 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11443606 }} </ref> | ||
* In 2008, Solar-Levy et al reported the presence of invasive lobular carcinoma in about 1.6% of patients with complex fibroadenomas and advised that any complex fibroadenoma with a high risk lesion on core biopsy should be excised. They also recommended that simple fibroadenomas with a volume growth rate of less than 16% per month (in patients younger than 50 years of age) and less than 13% per month (more than 50 years) should be followed up with imaging studies. | * In 2008, Solar-Levy et al reported the presence of invasive lobular carcinoma in about 1.6% of patients with complex fibroadenomas and advised that any complex fibroadenoma with a high risk lesion on core biopsy should be excised. They also recommended that simple fibroadenomas with a volume growth rate of less than 16% per month (in patients younger than 50 years of age) and less than 13% per month (more than 50 years) should be followed up with imaging studies.<ref name="pmid18094314">{{cite journal| author=Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B| title=Incidence and management of complex fibroadenomas. | journal=AJR Am J Roentgenol | year= 2008 | volume= 190 | issue= 1 | pages= 214-8 | pmid=18094314 | doi=10.2214/AJR.07.2330 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18094314 }} </ref><ref name="pmid25922691">{{cite journal| author=Sanders LM, Sara R| title=The growing fibroadenoma. | journal=Acta Radiol Open | year= 2015 | volume= 4 | issue= 4 | pages= 2047981615572273 | pmid=25922691 | doi=10.1177/2047981615572273 | pmc=4406922 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25922691 }} </ref><ref name="pmid14519878">{{cite journal| author=Gordon PB, Gagnon FA, Lanzkowsky L| title=Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up. | journal=Radiology | year= 2003 | volume= 229 | issue= 1 | pages= 233-8 | pmid=14519878 | doi=10.1148/radiol.2291010282 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14519878 }} </ref> | ||
==References== | ==References== | ||
Revision as of 00:00, 11 February 2019
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma historical perspective |
|
Risk calculators and risk factors for Fibroadenoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Historical Perspective
- In 1994, Dupont et al addressed in their retrospective cohort study that fibroadenoma is associated with a long term risk of invasive breast cancer, with the risk further increased in women with complex fibroadenomas, a family history of breast cancer and those with proliferative disease. Later in a study with Carter, they found that the presence of atypic within a fibroadenoma cannot foretell the presence of one in the adjacent breast parenchyma. They also found that atypia within a fibroadenoma does not present a relevant risk of development of breast cancer greater than that of a fibroadenoma with no atypia within.[1][2]
- In 2008, Solar-Levy et al reported the presence of invasive lobular carcinoma in about 1.6% of patients with complex fibroadenomas and advised that any complex fibroadenoma with a high risk lesion on core biopsy should be excised. They also recommended that simple fibroadenomas with a volume growth rate of less than 16% per month (in patients younger than 50 years of age) and less than 13% per month (more than 50 years) should be followed up with imaging studies.[3][4][5]
References
- ↑ Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS; et al. (1994). "Long-term risk of breast cancer in women with fibroadenoma". N Engl J Med. 331 (1): 10–5. doi:10.1056/NEJM199407073310103. PMID 8202095.
- ↑ Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA; et al. (2001). "No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia". Cancer. 92 (1): 30–6. PMID 11443606.
- ↑ Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B (2008). "Incidence and management of complex fibroadenomas". AJR Am J Roentgenol. 190 (1): 214–8. doi:10.2214/AJR.07.2330. PMID 18094314.
- ↑ Sanders LM, Sara R (2015). "The growing fibroadenoma". Acta Radiol Open. 4 (4): 2047981615572273. doi:10.1177/2047981615572273. PMC 4406922. PMID 25922691.
- ↑ Gordon PB, Gagnon FA, Lanzkowsky L (2003). "Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up". Radiology. 229 (1): 233–8. doi:10.1148/radiol.2291010282. PMID 14519878.